← Back to Search

Procedure

Pneumatic retinopexy for Retinal Detachment

N/A
Waitlist Available
Led By Rajeev Muni, FRSCS
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week, 1, 3, 6, 12 and 24 months post intervention
Awards & highlights

Study Summary

This trial will compare outcomes of two different surgeries for retinal detachment repair in terms of anatomical success, functional success and patient quality of life.

Eligible Conditions
  • Rhegmatogenous Retinal Detachment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week, 1, 3, 6, 12 and 24 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week, 1, 3, 6, 12 and 24 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Anatomical success (complete retinal re-attachment with no adjuvant surgical procedure)
Aniseikonia rates
Metamorphopsia rates
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: VitrectomyExperimental Treatment1 Intervention
Patients with retinal detachment allocated to vitrectomy
Group II: Pneumatic retinopexyExperimental Treatment1 Intervention
Patients with retinal detachment allocated to pneumatic retinopexy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vitrectomy
2013
Completed Phase 4
~2700
Pneumatic retinopexy
2012
N/A
~180

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
536 Previous Clinical Trials
447,351 Total Patients Enrolled
5 Trials studying Retinal Detachment
854 Patients Enrolled for Retinal Detachment
Rajeev Muni, FRSCSPrincipal Investigatorstaff
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Retinal Detachment
100 Patients Enrolled for Retinal Detachment
Verena Juncal, MDPrincipal Investigatorresearch fellow

Media Library

Pneumatic retinopexy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT02871531 — N/A
Retinal Detachment Research Study Groups: Vitrectomy, Pneumatic retinopexy
Retinal Detachment Clinical Trial 2023: Pneumatic retinopexy Highlights & Side Effects. Trial Name: NCT02871531 — N/A
Pneumatic retinopexy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02871531 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants currently being accepted into this experiment?

"Absolutely. According to clinicaltrials.gov, this investigation is still enrolling participants and began on November 1st 2016; the listing was most recently updated on August 21st 2019. The project requires 178 patients from two medical facilities."

Answered by AI

How many research subjects have signed up for this investigation?

"Affirmative. The clinicaltrials.gov webpage indicates that this trial is recruiting, beginning from November 1st 2016 with its last update occurring on August 21st 2019. As of now, 178 participants have been enrolled between two sites."

Answered by AI
~21 spots leftby Apr 2025